A Randomized Multi-centre Double-blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Nabiximols (Primary)
- Indications Gilles de la Tourette's syndrome; Tic disorders
- Focus Therapeutic Use
- Acronyms CANNA-TICS
- 29 Mar 2018 Status changed from not yet recruiting to recruiting.
- 27 Mar 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.
- 31 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Feb 2018.